Leigh MacMillan Archive — Page 3 of 85

Laboratory worker wearing a mask and blue gloves uses a pipette to transfer samples into a multiwell plate over a tray of ice and labeled tubes, surrounded by laboratory equipment.
June 9, 2026

Vanderbilt Health and UAB partner to help more clinicians use genomic medicine in everyday care

The project, called the Southeast Genomic Medicine Service, or SE-GEMS, will create a genomic eConsult service that allows clinicians to ask practical questions about genetic testing, test interpretation and next steps in care.

Glowing blue and magenta DNA double helix formed from particles, surrounded by streams of digital numbers and data-like light patterns.
May 29, 2026

AI technique improves cancer gene discovery for breast and prostate cancer

The artificial intelligence model Enformer was retrained with tissue-specific datasets; this “transfer learning” approach outperformed the base model in identifying disease-associated genes.

Three women at an indoor ceremony; the woman on the left holds a plaque, while the woman in the center holds a microphone and the woman on the right looks toward them. Plant leaves partially obscure the foreground.
May 14, 2026

Agnes Fogo receives lifetime achievement award for contributions to renal pathology

The award recognizes Fogo’s pioneering discoveries and lasting impact on understanding the pathophysiology and diagnosis of kidney disease.

Four graduates in gold and black academic regalia and velvet doctoral caps talk outdoors while holding blue programs before a commencement ceremony.
May 13, 2026

Commencement 2026: Biomedical sciences graduates challenged to be ‘opportunity detectives’

Dean C. André Christie-Mizell, PhD, told students at the Vanderbilt University Graduate School Commencement ceremony May 8 on Alumni Lawn that their graduate education had prepared them to think deeply, ask difficult questions and embrace uncertainty.

April 30, 2026

Disease-causing pathogen rewires gut metabolism to secure nutrients for growth: Study

The findings suggest that disease-associated microbes can actively drive intestinal inflammation by reshaping host metabolism, suggesting new therapeutic possibilities to prevent or disrupt diseases like infectious diarrhea and colorectal cancer.

Medical illustration showing a cluster of pink, rounded Acinetobacter bacteria against a dark blue background.
April 23, 2026

Gut microbiota impacts resistance to bacterial pneumonia: Study

The findings suggest the gut microbiota — microorganisms that live in the intestines — could be a therapeutic target to prevent hospital-acquired lung infections.